세계의 독성 약물 스크리닝 시장 보고서(2025년)
Toxicology Drug Screening Global Market Report 2025
상품코드 : 1769778
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 독성 약물 스크리닝 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 장래적 성장 요인으로는 맞춤형 의료 접근법의 급증, 의약품의 안전성에 대한 규제의 중점화, 대마초 및 합성 물질의 사용량 증가, 개발도상국에서의 광범위한 헬스케어 인프라의 정비, 약물 남용의 만연 등을 들 수 있습니다. 이 기간에 예측되는 주요 동향에는 고처리량 스크리닝 툴의 혁신, 독성학 분석에 있어서의 인공지능의 이용 강화, 포인트 오브 케어 독성학 진단의 출현, 바이오 마커 주도형 스크리닝 기술의 진보, 약물 스크리닝 워크플로우에 있어서의 자동화 및 로봇 시스템의 개선이 포함됩니다.

약물 남용 증가는 독성 약물 스크리닝 시장의 성장을 가속할 것으로 예측됩니다. 약물 남용 증가는 스트레스와 정신 위생 문제 증가로 인하여 많은 사람들이 대처법으로 약물을 사용하게 되었습니다. 2024년 8월, National Records of Scotland(NRS)은 2023년 약물 오용으로 인한 사망자 수를 1,172명으로 보고했습니다.

독성 약물 스크리닝 시장의 주요 기업은 임상, 법의학, 직장 환경에서 물질 검출의 정확성과 속도를 향상시키기 위해 법독성학 스크리닝과 같은 혁신적인 솔루션을 도입하고 있습니다. 예를 들어, 2022년 6월 미국 생명공학 및 생명과학기업인 Thermofisher Scientific은 임상 및 법의학 독성학 응용 분야를 위해 설계된 종합적인 LC-MS(액체 크로마토그래피 질량 분석) 시스템인 ToxSpec Analyzer를 출시했습니다. 이 솔루션은 하드웨어, 소프트웨어 및 검증 된 방법을 결합하여 약물 분석 스크리닝을 자동화하고 최적화하여 LC-MS/MS 경험이 풍부한 실험실에서도 이 기술을 활용할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Toxicology drug screening is a process designed to detect drugs, chemicals, or their metabolites in biological samples such as urine, blood, saliva, or hair. This type of medical testing is frequently utilized to identify both legal and illegal substances present in a person's system. Its primary purpose is to determine and assess drug exposure in an individual, serving a variety of needs depending on the application context.

Toxicology drug screening encompasses several major types, including monitoring and logging, security, storage, continuous integration or deployment, management and orchestration, networking, data management services, and others. Monitoring and logging refer to the ongoing tracking and documentation of data derived from tests and related activities. This category involves multiple test types such as acute systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, genotoxicity, neurotoxicity, and organ-specific toxicity. It also incorporates advanced technologies like high-throughput screening, genomics, transcriptomics, toxicogenomics, and molecular screening. Applications include immunotoxicity, systemic toxicity, developmental and reproductive toxicity (DART), endocrine disruption, among others. The end users of these screenings span across hospitals, clinics, contract research organizations (CROs), pharmaceutical firms, and workplace drug testing centers.

The toxicology drug screening market research report is one of a series of new reports from The Business Research Company that provides toxicology drug screening market statistics, including toxicology drug screening industry global market size, regional shares, competitors with a toxicology drug screening market share, detailed toxicology drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the toxicology drug screening industry. This toxicology drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The toxicology drug screening market size has grown strongly in recent years. It will grow from $19.56 billion in 2024 to $21.44 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The historical growth is driven by increasing instances of drug misuse, the introduction of workplace drug testing regulations, a rise in toxicology testing in athletic settings, the expansion of forensic toxicology capabilities, and the growing use of toxicology analysis in criminal investigations.

The toxicology drug screening market size is expected to see strong growth in the next few years. It will grow to $30.67 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. Contributing factors to this future growth include the surge in personalized medicine approaches, heightened regulatory emphasis on drug safety, an uptick in the usage of cannabis and synthetic substances, broader healthcare infrastructure development in developing countries, and the increasing prevalence of substance abuse. Key trends projected during this period involve innovations in high-throughput screening tools, enhanced use of artificial intelligence in toxicology analytics, the emergence of point-of-care toxicology diagnostics, progress in biomarker-driven screening techniques, and improved automation and robotic systems in drug screening workflows.

The increasing prevalence of drug abuse is anticipated to drive the growth of the toxicology drug screening market. Drug abuse refers to the harmful or excessive consumption of drugs for non-medical purposes, which adversely affects an individual's health and well-being. The rise in drug abuse is attributed to growing stress and mental health issues, prompting many to use substances as a coping mechanism. Toxicology drug screening plays a crucial role in detecting the presence of drugs or their metabolites in the body, facilitating early identification, diagnosis, and monitoring of substance misuse or overdose. For example, in August 2024, the National Records of Scotland (NRS), a government department in Scotland, reported 1,172 drug misuse deaths in 2023, reflecting a 12% increase (121 additional deaths) compared to 2022. As a result, the rising incidence of drug abuse is contributing to the expansion of the toxicology drug screening market.

Leading companies in the toxicology drug screening market are introducing innovative solutions such as forensic toxicology screening to improve the accuracy and speed of substance detection in clinical, forensic, and workplace environments. Forensic toxicology screening involves the examination of biological samples to identify drugs, poisons, or toxins associated with criminal investigations, accidents, or fatalities. For instance, in June 2022, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences firm, launched the ToxSpec Analyzer, a comprehensive LC-MS (liquid chromatography-mass spectrometry) system designed for clinical and forensic toxicology applications. This solution combines hardware, software, and validated methods to automate and optimize drug analyte screening, making the technology accessible even to labs with limited experience in LC-MS/MS. The ToxSpec Analyzer enhances operational efficiency, boosts identification accuracy, and allows laboratories to add new compounds as needed.

In September 2024, Scantox Group, a preclinical contract research organization based in Denmark that specializes in toxicology testing, acquired Gentronix for an undisclosed sum. The acquisition is intended to strengthen Scantox Group's early toxicity testing capabilities by incorporating Gentronix's expertise in genetic toxicology and predictive safety evaluation, thereby broadening its services for the pharmaceutical and chemical sectors. Gentronix, headquartered in the UK, is a preclinical contract research organization offering toxicology services, including drug screening.

Major players in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, and Alere Inc.

North America was the largest region in the toxicology drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in toxicology drug screening report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the toxicology drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The toxicology drug screening market consists of revenues earned by entities by providing services, such as pre-employment drug testing, sports drug testing, confirmatory testing, addiction treatment monitoring, and pain management monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Toxicology Drug Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on toxicology drug screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for toxicology drug screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The toxicology drug screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Toxicology Drug Screening Market Characteristics

3. Toxicology Drug Screening Market Trends And Strategies

4. Toxicology Drug Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Toxicology Drug Screening Growth Analysis And Strategic Analysis Framework

6. Toxicology Drug Screening Market Segmentation

7. Toxicology Drug Screening Market Regional And Country Analysis

8. Asia-Pacific Toxicology Drug Screening Market

9. China Toxicology Drug Screening Market

10. India Toxicology Drug Screening Market

11. Japan Toxicology Drug Screening Market

12. Australia Toxicology Drug Screening Market

13. Indonesia Toxicology Drug Screening Market

14. South Korea Toxicology Drug Screening Market

15. Western Europe Toxicology Drug Screening Market

16. UK Toxicology Drug Screening Market

17. Germany Toxicology Drug Screening Market

18. France Toxicology Drug Screening Market

19. Italy Toxicology Drug Screening Market

20. Spain Toxicology Drug Screening Market

21. Eastern Europe Toxicology Drug Screening Market

22. Russia Toxicology Drug Screening Market

23. North America Toxicology Drug Screening Market

24. USA Toxicology Drug Screening Market

25. Canada Toxicology Drug Screening Market

26. South America Toxicology Drug Screening Market

27. Brazil Toxicology Drug Screening Market

28. Middle East Toxicology Drug Screening Market

29. Africa Toxicology Drug Screening Market

30. Toxicology Drug Screening Market Competitive Landscape And Company Profiles

31. Toxicology Drug Screening Market Other Major And Innovative Companies

32. Global Toxicology Drug Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Toxicology Drug Screening Market

34. Recent Developments In The Toxicology Drug Screening Market

35. Toxicology Drug Screening Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기